Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
2
TGA:2
Drug Approvals
XEOMIN, incobotulinumtoxinA, 100 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial (205508)
- Product Name
- XEOMIN, incobotulinumtoxinA, 100 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial
- Approval Date
- Mar 21, 2014
TGA
XEOMIN, incobotulinumtoxinA, 50 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial (205507)
- Product Name
- XEOMIN, incobotulinumtoxinA, 50 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial
- Approval Date
- Mar 21, 2014
TGA
Clinical Trials
No trials found
News
No news found